On Wednesday, November 12th, Clarivate announced its 2025 list of Highly Cited Researchers, a list of influential scientific researchers and their associated institutions, and Professor Akihiko Yoshimura of the Faculty of Research Division, Organization for Research Advancement, Research Institute for Biomedical Sciences was selected among them.
Professor Yoshimura has been selected as one of 88 researchers from Japan for the 2025 list. Worldwide, 6868 researchers from 60 countries and regions were chosen this year.
The aim of the Highly Cited Researchers list is to identify and record those researchers who have had a significant impact on the research community, choosing scientists and social scientists who have published multiple papers that were in the top 1% of most cited papers worldwide for a given field in a given publication year and that have greatly influenced subsequent research.
Professor Yoshimura conducts research into immune tolerance and cancer immunity, and his published papers have been cited extensively in a range of fields, including immunology, leading to his selection as a highly influential researcher in the "cross-field" category.
■ Link
Clarivate 
Highly Cited Researchers
Remarks by Professor Yoshimura
Professor Akihiko Yoshimura
I have been researching the molecular mechanisms of immune diseases for many years and, in recent years, have expanded the scope of my research to include cancer treatment and brain diseases. I am extremely honored that my achievements have been recognized in this way, and I would like to express my sincere gratitude to my colleagues who have walked this path with me.
I would like to use the knowledge I have gained to date as a foundation for further efforts here at the Tokyo University of Science to develop new treatments that will save the lives of patients with intractable diseases such as cancer.
